61st ASH Annual Meeting and Exposition
Dec 7-10, 2019
Event Overview
VLS-101 is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) in Richter’s Syndrome (RS)
Authors
Tiziana Vaisitti, PhD, Katti Jessen, PhD, Thanh-Trang Vo, PhD, Mira Ko, Francesca Arruga, PhD, Nicoletta Vitale, PhD, Esteban Braggio, PhD, Arianna Di Napoli, Amy Chadburn, MD, John N. Allan, MD, Richard R. Furman, MD, Langdon L. Miller, Brian J. Lanutti, PhD, Silvia Deaglio, MD PhD